By Jennifer Permuth-Wey PhD (auth.), Samir A. Farghaly (eds.)
Ovarian melanoma: Advances in analysis and Management provides special foreign views in this devastating affliction. whereas ovarian melanoma has more often than not been thought of a illness of the Western hemisphere, this booklet strikes past our traditional knowing and embraces wisdom from worldwide. the point of interest is on contemporary advances in prognosis, together with genetic screening, and enhancements and increased offerings in administration, reminiscent of the optimization of chemotherapeutic brokers, gene remedy, and the newest laparoscopic and robot surgical concepts. additional chapters deal with psychosocial and quality-of-life matters. This booklet is a wonderful source at the overseas state of the art within the analysis and administration of ovarian melanoma and is aimed toward oncologists, gynecologists, and fellows.
Read Online or Download Advances in Diagnosis and Management of Ovarian Cancer PDF
Similar diagnosis books
Over the past decade, snapshot and sign compression for garage and transmission objective has obvious a superb enlargement. yet what approximately scientific facts compression? should still a clinical picture or a physiological sign be processed and compressed like several different info? The development made in imaging platforms, storing platforms and telemedicine makes compression during this box fairly fascinating.
Pack this useful consultant into your lab coat pocket and you are wearing a powerhouse of knowledge on greater than 500 issues. And it is going anyplace you pass - medical institution, sanatorium, rounds or perhaps reviewing for forums.
The foundation for the potent therapy and remedy of a sufferer is the fast analysis of the ailment and its causative agent, that is in response to the research of the scientific indicators coupled with laboratory checks. even if quick develop ments were made within the laboratory prognosis of virus ailments, the neces sary isolation of the causative virus from the scientific specimens is a comparatively lengthy approach.
From knowledgeable editor staff drawn from the Cochrane Neurological community, Evidence-Based Neurology presents experts and people in education with the abilities and data to use evidence-based perform within the medical atmosphere. fills the distance among directions and first experiences in addition to among basic and secondary clinical scientific literature summarizes the newest and significant findings on remedies for neurological sufferers measures the convenience and, while acceptable, the chance of damage inherent in particular neurological interventions now comprises new non-clinical subject matters of curiosity to neurologists similar to schooling and study
- Diagnosis and Treatment of Fetal Disorders: Proceedings of the International Symposium on Diagnosis and Treatment of Disorders Affecting the Intrauterine Patient Dorado, Puerto Rico, October 29–31, 1967
- Handbook of EEG Interpretation
- Prevention And Treatment Of Ischemic Stroke
- Tuberculosis and the Politics of Exclusion: A History of Public Health and Migration to Los Angeles (Critical Issues in Health and Medicine)
Additional resources for Advances in Diagnosis and Management of Ovarian Cancer
N Engl J Med. 1987;316(11):650–5. 85. Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol. 1989;161(1):10–6. 86. Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol. 1984;119(5):705–13. 87. Adami HO, Hsieh CC, Lambe M, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet. 1994;344(8932):1250–4.
Tzonou A, Day NE, Trichopoulos D, et al. The epidemiology of ovarian cancer in Greece: a casecontrol study. Eur J Cancer Clin Oncol. 1984;20(8): 1045–52. Kvale G, Heuch I, Nilssen S, Beral V. Reproductive factors and risk of ovarian cancer: a prospective study. Int J Cancer. 1988;42(2):246–51. McGowan L, Norris HJ, Hartge P, Hoover R, Lesher L. Risk factors in ovarian cancer. Eur J Gynaecol Oncol. 1988;9(3):195–9. Newhouse ML, Pearson RM, Fullerton JM, Boesen EA, Shannon HS. A case control study of carcinoma of the ovary.
This test is usually the most appropriate test for the first person to be tested from a family (see below for exceptions). In a small number of families, large-scale rearrangements are present and deletion/duplication analysis can detect large or multiexon 26 deletions, duplications, or rearrangements in BRCA1 or BRCA2. In some circumstances, more limited testing is appropriate as the initial test for a family. 5946delT in BRCA2), and testing for the presence or absence of these three mutations first is recommended for members of this group [14–16].